PINNACLE FINANCIAL PARTNERS INC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 111 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PINNACLE FINANCIAL PARTNERS INC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$45,990
-20.0%
1,0000.0%0.00%0.0%
Q2 2023$57,470
+53.3%
1,0000.0%0.00%0.0%
Q1 2023$37,500
+33.8%
1,0000.0%0.00%0.0%
Q4 2022$28,020
+0.1%
1,0000.0%0.00%0.0%
Q3 2022$28,000
-20.0%
1,0000.0%0.00%0.0%
Q2 2022$35,000
-2.8%
1,0000.0%0.00%0.0%
Q1 2022$36,000
+56.5%
1,0000.0%0.00%0.0%
Q4 2021$23,000
+21.1%
1,0000.0%0.00%0.0%
Q3 2021$19,000
-5.0%
1,0000.0%0.00%0.0%
Q2 2021$20,0000.0%1,0000.0%0.00%0.0%
Q1 2021$20,000
+5.3%
1,0000.0%0.00%0.0%
Q4 2020$19,0000.0%1,0000.0%0.00%0.0%
Q3 2020$19,000
-13.6%
1,0000.0%0.00%0.0%
Q2 2020$22,000
+46.7%
1,0000.0%0.00%0.0%
Q1 2020$15,000
-21.1%
1,0000.0%0.00%0.0%
Q4 2019$19,000
-5.0%
1,0000.0%0.00%
-50.0%
Q1 2019$20,000
+5.3%
1,0000.0%0.00%0.0%
Q3 2018$19,000
+26.7%
1,0000.0%0.00%
+100.0%
Q2 2018$15,000
-21.1%
1,0000.0%0.00%
-50.0%
Q1 2018$19,0001,0000.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q1 2020
NameSharesValueWeighting ↓
Campbell & CO Investment Adviser LLC 11,961$219,0000.13%
FEDERATED HERMES, INC. 3,441,367$63,046,0000.12%
CORNERCAP INVESTMENT COUNSEL INC 54,751$1,003,0000.11%
GSA CAPITAL PARTNERS LLP 34,425$631,0000.10%
First Trust Direct Indexing L.P. 11,913$218,0000.06%
Summit Global Investments 47,546$871,0000.06%
WINTON GROUP Ltd 49,766$912,0000.05%
FULLER & THALER ASSET MANAGEMENT, INC. 397,950$7,290,0000.05%
AIGEN INVESTMENT MANAGEMENT, LP 16,077$295,0000.04%
EXCHANGE TRADED CONCEPTS, LLC 52,334$959,0000.04%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders